Nuclear EGFR contributes to acquired resistance to cetuximab

Oncogene, 2009 - nature.com
Epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine
kinase involved in the etiology of several human cancers. Cetuximab is an EGFR-blocking …
被引用次数：366 相关文章

Nuclear EGFR contributes to acquired resistance to cetuximab

C Li, M Iida, EF Dunn, AJ Ghia, DL Wheeler - Oncogene, 2009 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine
kinase involved in the etiology of several human cancers. Cetuximab is an EGFR-blocking …

Nuclear EGFR contributes to acquired resistance to cetuximab

C Li, M Iida, EF Dunn, AJ Ghia, DL Wheeler - Oncogene, 2009 - go.gale.com
Epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine
kinase involved in the etiology of several human cancers. Cetuximab is an EGFR-blocking …
[PDF] researchgate.net

[PDF][PDF] Nuclear EGFR Contributes to Acquired Resistance to Cetuximab

C Li, M Iida, EF Dunn, AJ Ghia, DL Wheeler - Oncogene, 2009 - researchgate.net
Epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine
kinase involved in the etiology of several human cancers. Cetuximab is an EGFR blocking …
[HTML] nih.gov

[HTML][HTML] Nuclear EGFR Contributes to Acquired Resistance to Cetuximab

C Li, M Iida, EF Dunn, AJ Ghia, DL Wheeler - Oncogene, 2009 - ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine
kinase involved in the etiology of several human cancers. Cetuximab is an EGFR blocking …

[引用][C] Nuclear EGFR contributes to acquired resistance to cetuximab

C LI, M IIDA, EF DUNN, AJ GHIA… - Oncogene …, 2009 - pascal-francis.inist.fr
Nuclear EGFR contributes to acquired resistance to cetuximab CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Nuclear EGFR contributes to acquired resistance to cetuximab.

C Li, M Iida, EF Dunn, AJ Ghia, DL Wheeler - Oncogene, 2009 - europepmc.org
Epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine
kinase involved in the etiology of several human cancers. Cetuximab is an EGFR blocking …

[引用][C] Nuclear EGFR contributes to acquired resistance to cetuximab

C Li, M Iida, EF Dunn, AJ Ghia, DL Wheeler - Oncogene, 2009 - cir.nii.ac.jp
Nuclear EGFR contributes to acquired resistance to cetuximab | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Nuclear EGFR contributes to acquired resistance to cetuximab

C Li, M Iida, EF Dunn, AJ Ghia… - …, 2009 - mdanderson.elsevierpure.com
Epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine
kinase involved in the etiology of several human cancers. Cetuximab is an EGFR-blocking …

Nuclear EGFR contributes to acquired resistance to cetuximab.

C Li, M Iida, EF Dunn, AJ Ghia, DL Wheeler - Oncogene, 2009 - search.ebscohost.com
Epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine
kinase involved in the etiology of several human cancers. Cetuximab is an EGFR-blocking …